EverSource Wealth Advisors’s Organogenesis Holdings ORGO Stock Holding History

EverSource Wealth Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.66K	Buy	1,507 +1,224	+433%	+$2.99K	﹤0.01%	3440
2026 Q1	$670	Buy	283 +238	+529%	+$824	﹤0.01%	3983
2025 Q4	$233	Buy	+45	New	+$218	﹤0.01%	4011
2025 Q2	–	Sell	-252	Closed	-$1.09K	–	4329
2025 Q1	$1.09K	Buy	+252	New	+$1.02K	﹤0.01%	3201
2023 Q2	–	Sell	-894	Closed	-$1.9K	–	2574
2023 Q1	$1.9K	Sell	894 -1,609	-64%	-$3.98K	﹤0.01%	1945
2022 Q4	$6.73K	Buy	+2,503	New	+$7.3K	﹤0.01%	1484

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

EverSource Wealth Advisors's ORGO Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Organogenesis Holdings (ORGO) stake by 433% in Q2 2026, buying an estimated $2.99K and bringing the position to 1,507 shares worth $3.66K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

EverSource Wealth Advisors first reported a position in ORGO in Q4 2022 and has held it in 6 quarters since. The position peaked at $6.73K in Q4 2022. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

EverSource Wealth Advisors held 1,507 shares of Organogenesis Holdings worth $3.66K as of Q2 2026.
EverSource Wealth Advisors bought 1,224 Organogenesis Holdings shares in Q2 2026, an estimated $2.99K.
Organogenesis Holdings made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3440 holding.
EverSource Wealth Advisors first reported a position in Organogenesis Holdings in Q4 2022 and has held it in 6 quarters since.
EverSource Wealth Advisors's Organogenesis Holdings position peaked at $6.73K in Q4 2022.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.